Abstract:Kindlin-2 is involved in activating the integrin signaling pathway which plays an important role in regulating cancer cell invasion. However, the role of kindlin-2 may vary among cancer types. The aim of this study was to explore the possible association between kindlin-2 and clear cell renal cell carcinoma (ccRCC), and its potential role in the prognosis of ccRCC. Immunohistochemistry assays were used to examine kindlin-2 expression levels in cancer tissues obtained from 336 patients with ccRCC. The correlation between kindlin-2 expression levels and pathologic variables was then analyzed. In addition, the association between kindlin-2 expression levels and survival time was analyzed by Kaplan-Meier survival curves and log-rank tests. Of 336 ccRCC patients, 199 had high levels of kindlin-2 expression, while 137 had low kindlin-2 expression levels. Patients at a late stage of ccRCC (stage III or IV) were more likely to have high kindlin-2 expression levels than those at an early stage (stage I or II) (chi(2) = 4.72, P = 0.03). Patients with high levels of kindlin-2 expression had higher risk of hematogenous metastasis (chi(2) = 6.70, P = 0.01) than those with low levels of kindlin-2 expression. In addition, the survival time was significantly shorter for patients with high levels of kindlin-2 expression than for those with low levels of kindlin-2 expression (P = 0.001 for overall survival [OS] and P = 0.002 for disease-free survival [DFS]). Multivariate survival analysis based on the Cox proportional hazards model showed that high kindlin-2 expression levels had a hazard risk (HR) of 1.76 for OS (95% CI 1.19-2.62, P = 0.005) and an HR of 1.47 for DFS (95% CI = 1.05-2.06, P = 0.026). By comparison, lymph node metastasis had an HR of 1.48 for OS (95% CI 1.04-2.10, P = 0.029) and an HR of 1.41 for DFS (95% CI 1.04-1.93, P = 0.029). This study provided strong evidence that increased kindlin-2 expression might be involved in promoting tumor invasiveness and leading to a poor prognosis of ccRCC.

Clinical significance of Kindlin-2 protein in gastric cancer

Kindlin-2: a Novel Adhesion Protein Related to Tumor Invasion, Lymph Node Metastasis, and Patient Outcome in Gastric Cancer

Novel Focal Adhesion Protein Kindlin‐2 Promotes the Invasion of Gastric Cancer Cells Through Phosphorylation of Integrin Β1 and Β3

Kindlin-2: a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma.

Increased expression of kindlin-2 is correlated with hematogenous metastasis and poor prognosis in patients with clear cell renal cell carcinoma.

Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis

Expression and clinical significance of Gastrokine 2 in gastric cancer

Kindlin-2 Inhibits Serous Epithelial Ovarian Cancer Peritoneal Dissemination and Predicts Patient Outcomes.

Differential Expression of Kindlin-1 and Kindlin-2 Correlates with Esophageal Cancer Progression and Epidemiology

The Novel Focal Adhesion Gene Kindlin-2 Promotes the Invasion of Gastric Cancer Cells Mediated by Tumor-Associated Macrophages.

Expression of Kindlin-1 in Human Hepatocellular Carcinoma and Its Prognostic Significance

Kindlin-2 Promotes Clear Cell Renal Cell Carcinoma Progression Through the Wnt Signaling Pathway

The expression of Kindlin-2 in hepatocellular carcinoma and its relationship with tumor angiogenesis

Kindlin-2 Interacts with Β-Catenin and YB-1 to Enhance EGFR Transcription During Glioma Progression.

Kindlin-2 Induced by TGF-β Signaling Promotes Pancreatic Ductal Adenocarcinoma Progression Through Downregulation of Transcriptional Factor HOXB9

Role of Kindlin 2 in prostate cancer

Opposite Role of Kindlin-1 and Kindlin-2 in Lung Cancers

The Clinical Significance Of Her-2 And Nf-Kappa B Expression In Gastric Cancer

Identification and Validation of Kallikrein-Ralated Peptidase 11 As A Novel Prognostic Marker of Gastric Cancer Based on Immunohistochemistry

The clinical significance of HER-2 and NF-κB expression in gastric cancer

Kindlin-2 Promotes Genome Instability in Breast Cancer Cells